
UnitedHealth Group Inc, the largest U.S.
health insurer, has mentioned Gilead Sciences Inc's Harvoni as the preferred
hepatitis C treatment on its 2015 commercial drug coverage list.
According to sources, Gilead and AbbVie have been battling for hepatitis C
market share since the approval in December for an AbbVie drug that challenges
Gilead's blockbusters.
Advertisement
Insurers and third party administrators have been striking deals for preferred or exclusive status in exchange for discounts for 2015.
UnitedHealth's drug coverage list, which will be effective from February 1,
applies to all of the company's commercial, fully insured customers who use its
Optum RX pharmacy benefit manager and self-insured customers.
The update to the formulary which is available on the company's website also applies to its Medicaid, Medicare and military contracts.
UnitedHealth spokesman Tyler Mason said that, "We are constantly working to deliver value and manage costs for customers and consumers throughout our business."
Source: Medindia
Advertisement
The update to the formulary which is available on the company's website also applies to its Medicaid, Medicare and military contracts.
UnitedHealth spokesman Tyler Mason said that, "We are constantly working to deliver value and manage costs for customers and consumers throughout our business."
Source: Medindia
Advertisement
Advertisement
|
Advertisement
Recommended Reading
Latest Drug News

Microrobots could swirl through a person's blood stream, search for targeted areas to treat for various ailments.

Supplementation with multivitamins is an inexpensive way for older adults to slow down memory loss.

Some people with an aggressive blood cancer called acute myeloid leukemia (AML) may soon have a new drug option called Ivosidenib that blocks the activity of IDH1 gene.

In case of cardiac failure where the ejection fraction is greater than 40%, sacubitril/valsartan can prove to be quite beneficial

Acne treatment with anti-hypertensive drug is a valuable alternative to antibiotics, say physicians.